Navigation Links
New Elsevier Australia Nursing App – The Ideal Self-testing Tool
Date:5/15/2013

Sydney, New South Wales (PRWEB) May 15, 2013

Elsevier Australia has launched the first app in its Clinical Cases app series: 'Clinical Cases – Fundamentals of Nursing'.

A fun alternative study tool, this nursing app is purpose-designed for self-testing and easy revision.

Student nurses say one of the best things about using Clinical Cases apps will be the ability to study at their own pace. Like all good apps, this one can be used anywhere, at any time.

The complete 'Clinical Cases – Fundamentals of Nursing' app features: 24 progressive case studies with integrated multiple-choice questions and answer rationales; 150 flash cards to test nurses on key nursing definitions; timed word games and a medical glossary.

The initial download, priced at AUD$4.49, includes two detailed nursing case studies, flash cards, word puzzles and a glossary.

Nurses can then pick and choose from the remaining case studies, selecting the ones that best suit their needs.

They can buy the remaining 22 case studies at once, buy them one at a time, or purchase themed sets of two, such as Adolescent Mental Health and Mental Health 1 & 2 or Acute Care 1 & 2.

To further enhance their learning experience, nurses can use the app in conjunction with Elsevier Australia’s bestselling nursing textbook, Potter and Perry’s Fundamentals of Nursing, 4th ANZ Edition by Jackie Crisp, Catherine Taylor, Clint Douglas and Geraldine Rebeiro, and the accompanying Clinical Skills Workbook, 2nd Edition by Geraldine Rebeiro, Leanne Jack and app authors Natashia Scully and Damian Wilson.

The app is compatible with Apple iPhone (optimised for iPhone 5), iPod touch and iPad* and will soon also be available for android devices via Google Play.

The initial download of Clinical Cases – Fundamentals of Nursing is available now. Find it in the Apple App Store.

Learn more about the Clinical Cases – Fundamentals of Nursing app

*Devices require iOS 4.3 or later.

ABOUT ELSEVIER

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Read the full story at http://www.prweb.com/releases/Clinical/Cases/prweb10735670.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Elsevier and the ACC announce the launch of a new journal JACC: Heart Failure
2. Multiple Elsevier nursing titles honored by the American Journal of Nursing
3. Elsevier selected to publish Cytotherapy: The Journal of Cell Therapy
4. Elsevier launches new open access journal: Journal of Pediatric Surgery Case Reports
5. Elsevier launches new open access journal -- Epilepsy & Behavior Case Reports
6. Elsevier launches new open access journal: Leukemia Research Reports
7. Elsevier launches new journal: Health Care: The Journal of Delivery Science and Innovation
8. Elsevier congratulates its British Medical Association award winning medical authors and editors
9. Elsevier launches new journal: Performance Enhancement & Health
10. Elsevier announces publishing the Journal of Hospitality, Leisure, Sport and Tourism Education
11. Elsevier, SVS announce 2013 launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... RU (PRWEB) , ... June 26, 2017 , ... ... released a whitepaper that pledges to solve many catastrophic issues within funding campaigns. ... 2017. , The typical notion of crowdfunding - the raising of funds through the ...
(Date:6/25/2017)... ... ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows users ... contains 60 different color-grade presets, giving editors multiple options for adding different color options. ... subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any skill-set ...
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... 2017 , ... June is Men’s Health Month and the focus is on prostate ... in the U.S. and the third most common cause of cancer related death today; lung ... seven will be diagnosed with prostate cancer during his lifetime. Those at highest risk ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: